chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itching, redness, warmth and nickel size induration at the vaccine site. The induration enlarged to quarter size on Friday 8/8/14, with onset of diarrhea by 5pm. On Saturday 8/9/2014 the diarrhea resolved and the area on induration increased to the size of a golf ball. Sunday the induration decreased to size of quarter and Monday as of this writing is nickel sized.
I felt weak, nauseated, severe headache and body aches. I also had a fever of 102.3. Today is 10/10/2013 and I am still symptomatic!!!
This spontaneous report was received from a healthcare professional referring to a 12 months old female patient. Information about the patient's medical history and concurrent conditions was not reported. On 14-DEC-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L008270, expiration date 11-MAR-2017, (dose and route of administration were not provided). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information was received.
Information has been received from a nurse practitioner concerning a 12 month old male child with allergies to cats and eggs who was vaccinated with measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Concomitant therapy included varicella virus vaccine live and Hib conj vaccine given during the same visit.  The mother of the patient reported to the nurse practitioner that the patient experienced hives and difficulty breathing.  The nurse practitioner reported that the patient sought medical attention but was not seen by a health care professional during this experience.  Subsequently, the patient recovered from hives and difficulty breathing.  Additional information has been requested.
Adverse events between 8 to 12 days after receiving the first dose; This spontaneous case was reported by a health care professional and describes the occurrence of ADVERSE EVENT (Adverse events between 8 to 12 days after receiving the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced ADVERSE EVENT (Adverse events between 8 to 12 days after receiving the first dose). At the time of the report, ADVERSE EVENT (Adverse events between 8 to 12 days after receiving the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
red spot that keeps getting bigger and darker which is near the injection site, behind it and lower; Each day it gets bigger and redder; A spontaneous report was received from a nurse who was a 63-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed red spot that kept getting bigger and darker near the injection site, behind it and lower and each day it was getting bigger and redder.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Dec 2020, approximately 3 days prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot number: 011J20A) in the left arm for prophylaxis of COVID-19 infection.     On 29 Dec 2020, the patient developed a red spot located near the injection, behind it and lower than the injection site (it was not exactly located on the injection site). She stated that each day the spot was getting bigger and redder. She measured the size of redness with a measuring tape and noted that it was around 8 cm in diameter. The patient had not taken any medications or any treatment for the event.  Action taken with mRNA-1273 in response to the events was not reported.    The outcome for the events, red spot that keeps getting bigger and darker near the injection site, behind it and lower and each day it gets bigger and redder was not reported.; Reporter's Comments: This case concerns a 63-year-old, female patient. The patient's medical history was not provided. The patient experienced a NS, expected event of injection site erythema and injection site swelling. The event occurred 4 days after the first dose of mRNA-1273 (Lot number: 011J20A) administration. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This is a spontaneous report from a contactable consumer or other non healthcare professional. A 37 year old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 30Apr2021 12:00 (Batch/Lot Number: EW0175) as DOSE 2, SINGLE for covid-19 immunisation. Historical vaccine included bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Apr2021 12:00 (Batch/Lot Number: ER8729) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced muscle pain causing myalgia and low fever on 01May2021 with outcome of recovered.  Follow up (20May2021): This is a follow up spontaneous report from a contactable consumer. This 37-year-old female consumer (patient) reported that: The Batch/Lot Number and adverse events were updated.   Follow-up (24Jun2021): Follow-up attempts completed. No further information expected.
Shingles disease; Still has scabbing; Rash; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th October 2022, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles, scab and rash. On an unknown date, the outcome of the shingles, scab and rash were not recovered/not resolved.   It was unknown if the reporter considered the shingles, scab and rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 21-FEB-2023 Reporter's Comment:  The reporter reported that the patient received dose of Shingrix vaccine. The reporter stated that after received Shingrix vaccine since then the patient experienced shingles disease and was about 2 weeks into the disease. The reporter stated that the patient still had scabbing from the rash. The reporter did consent to follow up.
Approx 3 hrs after vaccine, reported scarlett fever type looking rash-on belly, arm pits and upper legs. Resolved after 3-4 days, denies sore throat, denies fever, throat appears normal
Pt recvd 1st dose of vax w/no noted problem; pt recvd 2nd dose of vax on 18AUG92 & w/in an hr following the vax, pt exp sore arm w/pain @ inject site; sx resolved w/in 24 hrs; No further details were provided;
Information has been received from a physician via a company representative concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history or concomitant medications were not reported. On 17-JAN-2014, the patient was vaccinated with a dose of PNEUMOVAX 23 2.5 ml, five dose vial, (lot number J004332, with expiration date of 26-SEP-2014) (route and anatomical location of administration were not reported) that was improperly stored. The lowest temperature excursion was of 32 degrees Fahrenheit (F) (0 Celsius) for a total of 72 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. Furthermore, no product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
throat began swelling up; hives; This is a spontaneous report from a contactable other HCP. A 30-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration from 06Jan2021 to 06Jan2021 at SINGLE DOSE for covid-19 immunisation.  Medical history included known allergies: PCN. The patient's concomitant medications were not reported. On 06Jan2021, the patient stated that his throat began swelling up and also had breaking out into hives. The patient underwent lab tests and procedures which included nasal swab (COVID test): negative on 19Dec2020. Therapeutic measures were taken as a result of pharyngeal swelling and hives included Benadryl. Outcome of the events was not recovered.   Information on the Lot/batch number has been requested.
Pt experienced redness, warmth, tenderness to left lateral thigh 48 hours post vax.
Had Chest pain early on June 3. Went to Emergency Room, transferred to other hospital,  Did blood tests, chest x-ray, heart ECHO, Venus Doppler.   June 4- blood tests, heart catherization. June 7- heart MRI. Diagnosed with myocarditis.  I have no history of heart issues prior to this.
Large ball at site redness spreading out gradually over 3 days now. Very sore hot to touch with swelling, tenderness. Blood sugar very high two days with standard medication. Day three still red large red spreading circle out to almost back of arm.
Intense pain beginning 9/25 on Right side of head above ear, lasting 10 seconds.  Then again beginning at 5:00 am  on 9/27 repeating every 30 to 60 seconds, continuing for 50 hrs., stopped on 9/28 at 10:00 pm.  Stopped for 9 days, then began again on 9/6/21 at 3:00pm.
p/recv vax pt devel hives over entire body; redness & swelling of ears, neck, trunk & thighs;DPH given for 3 days;
I had runny eyes, a lot of coughing, sneezing, it felt like a basic cold. I took a home COVID-19 test, it came back negative. I made an appointment at with my doctor. She did not retest me, she felt that from hearing me it sounded more like a viral cold. She recommended I take over the counter Mucinex DM. That did not help, I made another appointment and was given a prescription for benzonatate. It has helped a little. I was told that it could take several weeks for me to get over this cough.
fever 102F began on 24MAR93 screaming, crying for more than 3 hrs;
THIS VACCINE IS THE LEAST LIKELY  TO WORK ON ANYTHING, IT'S THE  WORST OF THE WORST/BLOOD TESTS SHOW THAT I DONT HAVE AN IMMUNITY; This spontaneous report received from a patient concerned a female of unspecified age with unspecified race & ethinicity. The patient's height, and weight were not reported. The patient's concurrent conditions included disabled. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, frequency 1 Total was administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  The patient reported that the vaccine was the least likely to work on anything, it was the worst of the worst, every time patient turns on the computer somebody was dying from a blood clot. Laboratory data (dates unspecified) included: Blood test (NR: not provided) lack of immunity. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of this vaccine was the least likely to work on anything, it was the worst of the worst/blood tests show that patient did not have an immunity was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000190591.; Sender's Comments: V0: 20210846262- covid-19 vaccine ad26.cov2.s-this vaccine was the least likely to work on anything, it was the worst of the worst/blood tests show that patient did not have an immunity (Drug ineffective). This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
given expired lot 10/1, but pfizer states stable till 10/19.  no adverse event.
Fever, Itchy painful rash at injection site. However, most unusual reaction was crusty eyes with a film/fluid minimizing eye sight for a few days.
Patient was administered 1st dosed but of expired vaccine ( temperature out of range ). Pfizer contacted and recommended to dose again. A valis 1st dose of the vaccine administered 03/19/21
Systemic: Fainting / Unresponsive-Severe, Additional Details: Patient fainted and regained consciousness. EMS was called
T 38 degrees C; c/o chest discomfort Advised to give Tylenol for temp, rest.  If symptoms not improve, go to ER for further evaluation (patient does not have primary MD)
57 year old female received vaccine 10/25/2010. 12-14 hours post vaccination pt. developed itchy hives and palpitations, heart rate between 104-196, persisting for 2 hours. There were 7 hives 1/2 inch in diameter on back and smaller hives on extremities. Hives on extremities resolved after 24 hours. Pt. called doctors office which advised BENADRYL. Pt. took BENADRYL on day 3 post vaccination, all symptoms resolved by day 5. Patient has a h/o hives one time when she was 7-8 years old, etiology was unknown.
Patient is a 69 y.o. female presenting to the ED for allergic reaction. Pt has flu vaccine at 10:30 this morning. She reports a possible allergic reaction with sx's of feeling nausea, dizziness, mouth swelling, hand numbness around 10:55 this morning after the vaccine. Pt denies any chills, fever, sore throat, SOB, CP, abdominal pain, diarrhea, vomiting, dysuria, back pain, pallor, rash, HA. The pt states she felt "weak" and had "trouble ambulating" to the ED room this afternoon. She denies any new laundry detergents or foods recently before arrival. The pt states she is on "some new medications" including Entresto. Pt denies taking any benadryl PTA. Hx of pulmonary clinic appointment this morning PTA. Hx of defibrillator.
Soon after pfizer booster, Pt started have symptoms of neuropoly.   Hands, and lower arms numb & tingly all the time.    He can feel things with his finger - no longer can:  shave, hold silverware correctly, he's spilling drinks, food.   He is getting more and more weak, he has fallen, his lumber & neck hurt.   Hard for him to walk
Patient reports adverse effects started approximately 8 pm on 3/18/2021, She experienced significant known adverse effects of the vaccine (reported severe fatigue, chills, pain in arm in which vaccine was administered) but also reports she was having great difficulty moving her neck. She reports that she was able to work (as a hair stylist) on 3/19 with more mild symptoms but still did not feel well and was still having difficulty moving her neck. She reported that she only realized on the afternoon of 3/20 that she had developed swelling at the base of her neck where it met her collarbone. She reported the swollen area was the size of a baseball and was red and warm. She indicated it was on the same side of her body as the vaccination site. She had not yet sought medical treatment when she contacted us but was going to have it examined. She called to notify the pharmacy so that we could report her condition but was not present at the pharmacy on 3/20.  Below item 21 is a required field and since she had not yet sought medical care but intended to this weekend I selected emergency room/department or urgent care.
Information has been received from a health professional concerning a 15 month old male with milk allergy and asthma who on 05-MAY-1997 was vaccinated with varicella virus vaccine (Oka/Merck). On 06-MAR-2007 the child was vaccinated subcutaneously in the right arm with his second dose of varicella virus vaccine live (Oka/Merck), (Lot#654756/1335F), and tetanus toxoid. On 08-MAR-2007 the patient experienced a red, swollen, warm and puffy area at the injection site. No treatment was required. The patient had an unknown reaction after the first vaccination. No lab diagnostic studies were performed. The patient's status at the time of the report was considered not recovered. Unspecified medical attention was sought. There was no product quality complaint. The office requested a lot check on Lot#654756/1335F. Additional information has been requested.
Headache, Myalgia, Arthralgia, Fever & Diarrhea Narrative: Rested at home Improved for a couple days, then symptoms intesifed.
This case was reported by a physician via call center representative and described the occurrence of eosinophilia in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, several days after receiving SHINGRIX, the patient experienced eosinophilia. On an unknown date, the outcome of the eosinophilia was unknown. It was unknown if the reporter considered the eosinophilia to be related to SHINGRIX. Additional information received as follows: The age at vaccination was not reported. The age group was not reported but was selected adult as per vaccine indication. Few days after receiving SHINGRIX, the patient had lab test which was resulted mild eosinophilia. The reporter asked if any data on this with SHINGRIX. Lab Comments: On an unknown date, lab test was performed.
A report has been from a consumer via market research organization concerning a two year-old female patient with height: 95 centimeters and weight: 14 kilograms. The patient's concurrent disease was reported as asthma. The patient's medical history was not reported. On an unspecified date the patient received nasal FLUENZ. During Oct-2012 after the vaccination with FLUENZ she suffered from severe fever, severe chills and joint pain which lasted three days. During Oct-2012 the patient recovered from the events. The report was considered to be non-serous by the reporter.
She only had a little aches with the first dose; This is a spontaneous report received from a contactable consumer (patient).   A 61-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL0140 and Expiration date was unspecified) on 24Dec2020 as single dose, unspecified route and location (at 61 years of age), for COVID-19 immunisation.  Medical history included that she has had Covid before and was in the hospital.  She lost 22 pounds because she couldn't eat. No concomitant medication was reported.  The patient reported She only had little aches with the first dose on an unspecified date.  Outcome of event for aches was unknown.
Chills starting in upper left quadrant of back and feeling of sunburn hypersensitivity starting on 5/13/21, Dailey spread across back then chest, then stomach and down legs.  No rash no fever, then aches and pain feeling in same areas.  Then spread sunburn feeling up neck to bask of skull with aching pains on both sides of neck.  Scalp  now painful to touch and have chills radiating through body when exposed to cold air.  Skin hyper sensitive to shower (hot or cold)with pain like needles
Pt had vaccines, 1 day, before he turned 1 year old. The office realized this mistake and had him come in 10/24/00 for repeat vaccines and within 4 days, post vax, he had a rash that would disappear and appear in other areas. He was in the hospital from 10/2/00 to 10/6/00 for rotavirus and concerned with enough recovery time before shots. State is cracking down on vaccinations before 12 months and he was 1 day shy of that.
I received my Moderna booster on 11/11/2021. On the evening of 9/11/2022, I began having flulike symptoms. I felt achy and had head congestion. I decided to take a home test for COVID-19, because I help care for my elderly mother, and I didn't want to jeopardize her health. The result was positive. I texted my doctor to inform him of the situation, and he instructed me to self-isolate for 10 days. I wasn't prescribed anything and I didn't develop any other symptoms besides the ones I just mentioned. It felt more like a light cold than anything, and by the time 9/15/2022 rolled around, I felt fine. I took some extra strength TYLENOL the first day for relief, and that was pretty much the only time I ever needed medication. On 9/21/2022, I took another home test, and the result was positive. I texted my doctor to let him know, but he told me that since 10 days had passed, it was still safe for me to end my isolation, though he did recommend that I wear a mask if I was going to be around others.
Bells palsy effect; Rapid heartbeat; Numb nose, nasal cavity, cheeks; Numb eyelids; A spontaneous report was received from a consumer, concerning a 65 year-old, female who received Moderna's COVID-19 vaccine (mRNA-1273) and developed a rapid heartbeat/tachycardia, her nose, nasal cavity, cheeks and eyelids were numb/hypoaesthesia, Bell's palsy effect/facial paralysis.  The patient's medical history included were overweight and pre diabetic. The patient was allergic to latex and was dairy sensitive was not provided. Concomitant product included was vitamins.  On 16 Feb2021, few minutes prior to the onset of symptoms, the patient received her first of two planned doses of mRNA-1273 (batch number: 004M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient, while she was staying for 15 minutes in the facility, she felt a rapid heartbeat. It was not alarming, but it was faster than normal. Five minutes after leaving the facility, which was 20 minutes after she received the vaccine, her nose, nasal cavity, cheeks and eyelids were numb. This numbness stayed for two hours and the disappeared. The numb sensation on the nose stayed for 3 whole days after the vaccine was administered. The patient consulted the primary doctor, who stated that it was a Bells Palsy effect. Treatment information was not provided.  The outcome of the events of rapid heartbeat, nose, nasal cavity, cheeks and eyelids were numb were considered recovered and the outcome for Bells palsy effect was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Slept constantly for the first 24 hours. Excessive crying the 2nd 24 hours. Projectile vomiting X 1, today (11/9/00).
Patient reported the area around the injection site swelled to the size of a tennis ball and was bright red, hot to the touch and burned. This continued for a couple of weeks after the vaccination. Patient reported putting heating pads on the area but no other treatment was received. She reported that she has gotten the flu shot for the past 12 years and usually it becomes slightly red in a small area around the injection site but this was much worse. When she presented to the pharmacy on 1/27/18 the swelling and redness had subsided and the area was back to normal. Pharmacy was not made aware of this incident until 1/27/18 by patient.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment medication was not provided.   Reporter did not allow further contact